Novo Nordisk to supply insulin at discount to poorest nations

NEW YORK, Sept 21 (Reuters) - Danish drugmaker Novo Nordisk

A/S on Wednesday pledged to provide insulin at

steeply discounted prices in the world's least-developed nations

in what it is calling its "access to insulin commitment."

Read more